APA (7th ed.) Citation

JJ, S., YJ, Y., YY, T., S, Y., MD, Y., WH, C., & LL, X. (2026). m6A-modified Mid1 promotes sevoflurane-induced cognitive impairment in neonatal mice by ubiquitin-mediated degradation of Syngap1. Experimental & molecular medicine, 58(6), 1914. https://doi.org/10.1038/s12276-026-01747-7

Chicago Style (17th ed.) Citation

JJ, Shen, Yang YJ, Tang YY, Yan S, Ying MD, Chen WH, and Xu LL. "M6A-modified Mid1 Promotes Sevoflurane-induced Cognitive Impairment in Neonatal Mice by Ubiquitin-mediated Degradation of Syngap1." Experimental & Molecular Medicine 58, no. 6 (2026): 1914. https://doi.org/10.1038/s12276-026-01747-7.

MLA (9th ed.) Citation

JJ, Shen, et al. "M6A-modified Mid1 Promotes Sevoflurane-induced Cognitive Impairment in Neonatal Mice by Ubiquitin-mediated Degradation of Syngap1." Experimental & Molecular Medicine, vol. 58, no. 6, 2026, p. 1914, https://doi.org/10.1038/s12276-026-01747-7.